Rare diseases
Investigational molecules
Locations
Back to Czechia1 218 clinical trials in Prague, Czechia across 18 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)A study testing vipoglanstat for women with moderate to severe endometriosis-related pain
CzechiaA Study of GSK4524101 and Niraparib for Adults with Advanced Solid Tumors or Metastatic Breast Cancer with BRCA Gene Changes
CzechiaA study testing cagrilintide for weight loss in people with overweight or obesity and type 2 diabetes
CzechiaA Study of Ianalumab and Eltrombopag for Patients with Primary Immune Thrombocytopenia Who Did Not Respond Well to or Relapsed After Steroid Treatment
CzechiaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
CzechiaA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
CzechiaStudy of Cromolyn Inhalation Treatment for Patients with Mild to Moderate Amyotrophic Lateral Sclerosis (ALS)
CzechiaStudy of ritlecitinib for treating severe alopecia areata in children aged 6 to under 12 years
CzechiaStudy comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy
CzechiaLong-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation
CzechiaStudy of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years
CzechiaStudy of SAR441566 and methotrexate in adults with moderate to severe rheumatoid arthritis
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Clinical trial activity in Praha includes research in advanced melanoma and diffuse large B-cell lymphoma, with a strong focus on improving cancer control and extending survival.
These studies are designed to refine how immunotherapy and other cancer treatments perform in everyday clinical care.
Research in cardiovascular diseases is centered on reducing major heart and vascular events, with trials looking at hypertension, atherosclerotic cardiovascular disease, and heart failure prevention.
Several studies aim to improve treatment effectiveness for patients at elevated cardiovascular risk.
Trials in the respiratory field focus on better symptom control and fewer flare-ups in chronic obstructive pulmonary disease, alongside ongoing work in infection-related lung illness.
These studies support more effective care for both chronic and acute respiratory conditions.
Dermatology research in Czechia includes several inflammatory skin disorders, with studies targeting itch, lesion control, and long-term disease management.
The goal is to evaluate new therapies that may ease symptoms and improve quality of life.
Studies in immune-mediated disease are exploring treatments that can calm abnormal inflammation while maintaining safety and tolerability.
These trials aim to improve control of chronic immune-driven disease burden.
Neurology-related research focuses on agitation in Alzheimer's disease dementia, with efforts to better manage behavioral symptoms that affect patients and caregivers.
These studies may help support more practical care for people living with dementia.
Metabolic research in Praha includes trials for overweight, obesity, and related conditions, often linked with cardiovascular risk.
These studies are testing approaches that may help reduce long-term health risks tied to excess weight.
In the area of virus diseases, research is centered on improving treatment options for people with COVID-19 who are at higher risk of becoming seriously ill.
The main aim is to help prevent worsening disease and support faster recovery.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
